Display options
Cite
Fallon EA, Chun TT, Young WA, et al. Program Cell Death Receptor-1-Mediated Invariant Natural Killer T-Cell Control of Peritoneal Macrophage Modulates Survival in Neonatal Sepsis. Front Immunol. 2017;8:1469doi: 10.3389/fimmu.2017.01469.
Fallon, E. A., Chun, T. T., Young, W. A., Gray, C., Ayala, A., & Heffernan, D. S. (2017). Program Cell Death Receptor-1-Mediated Invariant Natural Killer T-Cell Control of Peritoneal Macrophage Modulates Survival in Neonatal Sepsis. Frontiers in immunology, 81469. https://doi.org/10.3389/fimmu.2017.01469
Fallon, Eleanor A, et al. "Program Cell Death Receptor-1-Mediated Invariant Natural Killer T-Cell Control of Peritoneal Macrophage Modulates Survival in Neonatal Sepsis." Frontiers in immunology vol. 8 (2017): 1469. doi: https://doi.org/10.3389/fimmu.2017.01469
Fallon EA, Chun TT, Young WA, Gray C, Ayala A, Heffernan DS. Program Cell Death Receptor-1-Mediated Invariant Natural Killer T-Cell Control of Peritoneal Macrophage Modulates Survival in Neonatal Sepsis. Front Immunol. 2017 Nov 20;8:1469. doi: 10.3389/fimmu.2017.01469. eCollection 2017. PMID: 29209308; PMCID: PMC5701916.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2017 Nov 20;8:1469. doi: 10.3389/fimmu.2017.01469. eCollection 2017.

Program Cell Death Receptor-1-Mediated Invariant Natural Killer T-Cell Control of Peritoneal Macrophage Modulates Survival in Neonatal Sepsis.

Frontiers in immunology

Eleanor A Fallon, Tristen T Chun, Whitney A Young, Chyna Gray, Alfred Ayala, Daithi S Heffernan

Affiliations

  1. Division of Surgical Research, Department of Surgery, Brown University and Rhode Island Hospital, Providence, RI, United States.

PMID: 29209308 PMCID: PMC5701916 DOI: 10.3389/fimmu.2017.01469

Abstract

We have shown that invariant natural killer T (

Keywords: invariant natural killer T cells; neonatal; peritoneal macrophage; programmed cell death receptor-1; sepsis

References

  1. Curr Opin Immunol. 2010 Jun;22(3):397-401 - PubMed
  2. Surgery. 2017 May;161(5):1387-1393 - PubMed
  3. Front Immunol. 2015 Aug 12;6:401 - PubMed
  4. Clin Immunol. 2011 Aug;140(2):117-8 - PubMed
  5. Immunology. 2010 Oct;131(2):289-99 - PubMed
  6. Shock. 2007 Dec;28(6):675-683 - PubMed
  7. Curr Opin Pediatr. 2016 Apr;28(2):135-40 - PubMed
  8. Hepatology. 2004 Aug;40(2):346-55 - PubMed
  9. Int J Infect Dis. 2017 Mar;56:221-228 - PubMed
  10. Life Sci. 2012 Jan 30;90(5-6):177-84 - PubMed
  11. Nat Immunol. 2010 Apr;11(4):295-302 - PubMed
  12. Nature. 2014 Nov 27;515(7528):568-71 - PubMed
  13. J Immunol. 2012 May 15;188(10):4876-84 - PubMed
  14. J Leukoc Biol. 2010 Aug;88(2):233-40 - PubMed
  15. Front Pediatr. 2017 Feb 07;5:14 - PubMed
  16. Sci Signal. 2011 Sep 6;4(189):ra57 - PubMed
  17. J Immunol. 2011 May 15;186(10):5758-65 - PubMed
  18. Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10 ):590-600 - PubMed
  19. Scand J Immunol. 2016 Apr;83(4):255-66 - PubMed
  20. Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6303-8 - PubMed
  21. Clin Immunol. 2011 Aug;140(2):130-41 - PubMed
  22. Shock. 2011 Aug;36(2):138-43 - PubMed
  23. Mucosal Immunol. 2014 Sep;7(5):1233-43 - PubMed
  24. Shock. 2016 May;45(5):534-9 - PubMed
  25. Shock. 2013 Aug;40(2):122-8 - PubMed
  26. Immunity. 2014 Jul 17;41(1):21-35 - PubMed
  27. Immunol Rev. 2013 Nov;256(1):222-39 - PubMed
  28. J Exp Med. 2000 Oct 2;192(7):1027-34 - PubMed
  29. Nat Rev Immunol. 2013 Feb;13(2):101-17 - PubMed
  30. Clin Perinatol. 2010 Jun;37(2):439-79 - PubMed
  31. J Immunol. 2009 Feb 15;182(4):2467-75 - PubMed
  32. J Immunol. 2011 Apr 1;186(7):4490-9 - PubMed
  33. Antivir Ther. 2009;14(6):809-18 - PubMed
  34. Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):E1101-10 - PubMed
  35. Front Immunol. 2015 May 20;6:240 - PubMed
  36. Front Immunol. 2016 Dec 12;7:550 - PubMed
  37. Annu Rev Immunol. 2007;25:297-336 - PubMed
  38. J Pediatr Surg. 1991 Apr;26(4):494-7; discussion 497-9 - PubMed
  39. Immunobiology. 2014 Oct;219(10):756-65 - PubMed
  40. Trends Mol Med. 2016 Apr;22(4):290-302 - PubMed
  41. J Am Chem Soc. 2004 Oct 27;126(42):13602-3 - PubMed
  42. JAMA. 2016 Feb 23;315(8):801-10 - PubMed
  43. Vaccine. 2014 Oct 21;32(46):6138-45 - PubMed
  44. Hum Immunol. 2014 Mar;75(3):277-82 - PubMed
  45. Anat Rec (Hoboken). 2010 Oct;293(10):1698-710 - PubMed
  46. J Clin Invest. 2015 Sep;125(9):3384-91 - PubMed
  47. Front Immunol. 2015 May 13;6:226 - PubMed

Publication Types

Grant support